BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,695,462 | -64.3% | 366,450 | -68.2% | 0.04% | -66.9% |
| Q1 2023 | $46,772,087 | -41.5% | 1,153,158 | -26.5% | 0.13% | -45.9% |
| Q4 2022 | $79,992,726 | -59.0% | 1,569,408 | -56.7% | 0.25% | -56.7% |
| Q3 2022 | $195,225,000 | -16.2% | 3,624,666 | -0.0% | 0.57% | -11.4% |
| Q2 2022 | $232,883,000 | -21.8% | 3,625,766 | -5.6% | 0.64% | -8.0% |
| Q1 2022 | $297,937,000 | -28.2% | 3,842,366 | -20.5% | 0.70% | -22.3% |
| Q4 2021 | $414,939,000 | -26.5% | 4,833,866 | -31.2% | 0.90% | -25.4% |
| Q3 2021 | $564,779,000 | -7.8% | 7,022,000 | -7.7% | 1.20% | -9.1% |
| Q2 2021 | $612,605,000 | -8.3% | 7,610,000 | -4.0% | 1.32% | -12.2% |
| Q1 2021 | $668,280,000 | +2.0% | 7,923,641 | -2.9% | 1.51% | -0.7% |
| Q4 2020 | $655,084,000 | +3.4% | 8,164,063 | +3.7% | 1.52% | -10.2% |
| Q3 2020 | $633,249,000 | -3.3% | 7,874,269 | +3.5% | 1.69% | -8.4% |
| Q2 2020 | $655,063,000 | +6.0% | 7,608,169 | -0.1% | 1.84% | -5.5% |
| Q1 2020 | $618,170,000 | +8.3% | 7,613,869 | +11.5% | 1.95% | +40.5% |
| Q4 2019 | $570,788,000 | +1.4% | 6,825,969 | +6.1% | 1.39% | +1.1% |
| Q3 2019 | $562,839,000 | +6.9% | 6,434,655 | +0.1% | 1.37% | +4.7% |
| Q2 2019 | $526,655,000 | +44.4% | 6,430,469 | +43.4% | 1.31% | +41.7% |
| Q1 2019 | $364,648,000 | +49.6% | 4,484,669 | +21.1% | 0.92% | +38.7% |
| Q4 2018 | $243,815,000 | +2484.7% | 3,704,269 | +2927.1% | 0.67% | +2931.8% |
| Q3 2018 | $9,433,000 | +0.1% | 122,369 | -4.2% | 0.02% | 0.0% |
| Q2 2018 | $9,427,000 | -2.6% | 127,669 | -14.2% | 0.02% | -4.3% |
| Q1 2018 | $9,676,000 | -1.6% | 148,769 | -2.2% | 0.02% | 0.0% |
| Q4 2017 | $9,830,000 | -30.1% | 152,069 | -31.9% | 0.02% | -28.1% |
| Q3 2017 | $14,063,000 | +6.5% | 223,169 | +2.1% | 0.03% | 0.0% |
| Q2 2017 | $13,201,000 | -1.6% | 218,669 | -15.4% | 0.03% | -3.0% |
| Q1 2017 | $13,419,000 | -0.8% | 258,469 | -15.4% | 0.03% | -2.9% |
| Q4 2016 | $13,523,000 | -26.3% | 305,369 | -20.7% | 0.03% | -26.1% |
| Q3 2016 | $18,339,000 | +123.1% | 385,269 | +112.0% | 0.05% | +119.0% |
| Q2 2016 | $8,219,000 | +117.5% | 181,751 | +97.6% | 0.02% | +110.0% |
| Q1 2016 | $3,779,000 | -57.4% | 92,000 | -60.4% | 0.01% | -58.3% |
| Q4 2015 | $8,870,000 | +12.0% | 232,500 | -3.5% | 0.02% | +9.1% |
| Q3 2015 | $7,917,000 | -52.6% | 241,000 | +0.8% | 0.02% | -50.0% |
| Q2 2015 | $16,713,000 | +1.9% | 239,000 | -0.2% | 0.04% | -4.3% |
| Q1 2015 | $16,406,000 | -14.9% | 239,500 | -8.9% | 0.05% | -9.8% |
| Q4 2014 | $19,275,000 | -6.3% | 263,000 | -8.2% | 0.05% | -8.9% |
| Q3 2014 | $20,562,000 | -4.1% | 286,500 | -3.4% | 0.06% | -5.1% |
| Q2 2014 | $21,451,000 | -6.5% | 296,700 | -4.8% | 0.06% | -14.5% |
| Q1 2014 | $22,935,000 | +7.8% | 311,700 | +1.9% | 0.07% | +6.2% |
| Q4 2013 | $21,282,000 | -46.3% | 306,000 | -49.3% | 0.06% | -42.5% |
| Q3 2013 | $39,637,000 | -4.6% | 603,400 | +0.6% | 0.11% | -5.8% |
| Q2 2013 | $41,541,000 | – | 599,700 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |